Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Case report: acute tumour lysis syndrome following encorafenib and binimetinib for v600E metastatic melanoma with large intra-abdominal mass.

Melanoma research - 1 Dec 2020

Byron Yoni, Nott Louise, Shackleton Mark

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Benzimidazoles
Share to Carbamates
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Sulfonamides

Source

Identifiers

PMID: 32976221
DOI: 10.1097/CMR.0000000000000696

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Case report: acute tumour lysis syndrome following encorafenib and binimetinib for v600E metastatic melanoma with large intra-abdominal mass.PMID 32976221Read ↗

Ruxolitinib withdrawal syndrome leading to tumor lysis.Semantic proximity Read ↗

Tumor Lysis Syndrome in a Patient with BRAFV600E Mutated Colon Cancer Treated with Cetuximab and Encorafenib.Semantic proximity Read ↗

[Dramatic response to encorafenib plus binimetinib in a patient with leukemoid reaction from metastatic melanoma.]Semantic proximity Read ↗

Multiple bone metastases in advanced breast cancer: a gastrointestinal surgical emergencySemantic proximity Read ↗

Hemorrhage of liver and bone metastases as a result of rapid response to dual BRAF/MEK inhibition in metastatic melanoma: a case report.Semantic proximity Read ↗

Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity Read ↗

Panniculitis during avapritinib therapy for gastrointestinal stromal tumour.Semantic proximity Read ↗

Relatively mild symptoms after chronic overdose with a double-dose encorafenib: a case report.Semantic proximity Read ↗

Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report.Semantic proximity Read ↗

Paraneoplastic leukemoid reaction in a patient with BRAF V600E-mutated metastatic malignant melanoma.Semantic proximity Read ↗

Research letter: BRAF-inhibitor induced panniculitis - A systematic review.Semantic proximity Read ↗

[Unusual association of BRAF and MEK inhibitors: Clinical response of metastatic melanoma treated with dabrafenib-cobimetinib].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.